NasdaqCM - Nasdaq Real Time Price USD

Werewolf Therapeutics, Inc. (HOWL)

0.9888 +0.0988 (+11.10%)
At close: 4:00:01 PM EDT
0.9651 -0.0237 (-2.40%)
After hours: 5:13:15 PM EDT
Chart Range Bar
Loading chart for HOWL
  • Previous Close 0.8900
  • Open 0.9000
  • Bid 0.7280 x 200
  • Ask 1.1600 x 200
  • Day's Range 0.9000 - 1.0500
  • 52 Week Range 0.2700 - 2.3800
  • Volume 11,505,650
  • Avg. Volume 6,703,333
  • Market Cap (intraday) 48.055M
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) --
  • EPS (TTM) -0.7300
  • Earnings Date (est.) Oct 30, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.00

Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PREDATOR platform. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; WTX-921, a conditionally activated IL-10 INDUKINE molecule for the treatment of inflammatory bowel disease and potentially other inflammatory diseases; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. In addition, it develops WTX-1011, a conditionally activated INDUCER T cell engager molecule that targets STEAP 1 for prostate cancer, as well as WTX-2022 that targets CDH6 for ovarian and kidney cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.

werewolftx.com

39

Full Time Employees

December 31

Fiscal Year Ends

Performance Overview

Trailing total returns as of 8/26/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HOWL
55.96%
S&P 500 (^GSPC)
12.13%

1-Year Return

HOWL
27.29%
S&P 500 (^GSPC)
18.71%

3-Year Return

HOWL
67.69%
S&P 500 (^GSPC)
74.22%

5-Year Return

HOWL
94.17%
S&P 500 (^GSPC)
71.72%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 21M
Earnings 3.67M
Profit Margin 17.48%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-10M
0
10M
20M
0.0%
5.0%
10.0%
15.0%
 

Analyst Insights

View More

Analyst Price Targets

4.00
7.00 Average
0.9888 Current
10.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Latest Rating

Date 12/19/2025
Analyst HC Wainwright & Co.
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 10 -> 4
 

Statistics

View More

Valuation Measures

Annual
As of 8/25/2026
  • Market Cap

    42.87M

  • Enterprise Value

    20.88M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.05

  • Price/Book (mrq)

    2.63

  • Enterprise Value/Revenue

    1.00

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -164.82%

  • Return on Assets (ttm)

    -27.39%

  • Return on Equity (ttm)

    -119.86%

  • Revenue (ttm)

    21M

  • Net Income Avi to Common (ttm)

    -34.61M

  • Diluted EPS (ttm)

    -0.7300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.99M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -12.23M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.9888 Current
 

Dividend Score

0 Low
Sector Avg.
100 High
 

Hiring Score

0 Low
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
Sector Avg.
100 High
 

People Also Watch